Anfotericina B: uma revisão sobre suas diferentes formulações, efeitos adversos e toxicidade
Falci, Diego Rodrigues; Pasqualotto, Alessandro Comarú.
Clin. biomed. res
; 35(2): 65-82, 2015. ilus, tab
Artículo en Portugués | LILACS | ID: lil-780253
Documentos relacionados
Scalable Production of Lipid Nanoparticles Containing Amphotericin B.
Amphotericin B nephrotoxicity.
Conjugates of amphotericin B to resolve challenges associated with its delivery.
Distearoyl phosphatidylglycerol and dioleoyl phosphatidylglycerol increase the retention and reduce the toxicity of amphotericin B-loaded in nanoemulsions.
Design, Synthesis, and Structure-Activity Relationship Studies of Bisamide Derivatives of Amphotericin B with Potent Efficacy and Low Toxicity.
Galleria mellonella for systemic assessment of anti-Candida auris using amphotericin B loaded in nanoemulsion.
Amphotericin B nanohydrogel ocular formulation using alkyl glyceryl hyaluronic acid: Formulation, characterization, and in vitro evaluation.
Self-Assembled Teicoplanin Micelles as Amphotericin B Nanocarrier.
Physicochemical surrogates for in vitro toxicity assessment of liposomal amphotericin B.
In vitro evaluation of antileishmanial activity, mode of action and cellular response induced by vanillin synthetic derivatives against Leishmania species able to cause cutaneous and visceral leishmaniasis.